Epclusa الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

epclusa

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatitída c, chronická - antivirotiká na systémové použitie - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 a 5.

Harvoni الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

harvoni

gilead sciences ireland uc - ledipasvir, sofosbuvir - hepatitída c, chronická - antivirotiká na systémové použitie - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 a 5. pre vírusom hepatitídy c (hcv) genotyp-konkrétne aktivity pozri časť 4. 4 a 5.

Vosevi الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitída c, chronická - antivirotiká na systémové použitie - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (pozri časť 4. 2, 4. 4 a 5.

SPORANOX سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sporanox

johnson & johnson, s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)

SERLIFT 50 mg سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

serlift 50 mg

adamed czech republic s.r.o., Česká republika - sertralín - 30 - antidepressiva

SERLIFT 100 mg سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

serlift 100 mg

adamed czech republic s.r.o., Česká republika - sertralín - 30 - antidepressiva

Tecovirimat SIGA الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

tecovirimat siga

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirotiká na systémové použitie - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 a 5. tecovirimat siga should be used in accordance with official recommendations.